Validation of French Version of LCADL and Dyspnea-12

University Hospital, Brest50 enrolled

Overview

The main objective of this study is to develop and to validate a French version of the London Chest Activity of Daily Living (LCADL) and the Dyspnea 12 and to determine the reliability of this version for the evaluation of the dyspnea in the Activity of Daily Living in COPD patients (stages severe and very severe).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Copd

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * COPD with FEV1\< 50% of predictive value Exclusion Criteria: * FEV1\> 50% of predictive value * Patients with an exacerbation of COPD in the previous 30 days the inclusion

Locations (1)

Brest University hospital

Morlaix, France

Outcomes

Primary Outcomes

the Saint-Georges questionnaire, item Activity

by comparison with item activities of the Saint-Georges questionnaire for the LCADL

Time frame: 15 days

MMRC Dyspnea scale

by comparison with MMRC dyspnea scale for the dyspnea 12

Time frame: 15 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.